» Articles » PMID: 21183127

New Drugs for Pediatric Epilepsy

Overview
Specialties Neurology
Pediatrics
Date 2010 Dec 25
PMID 21183127
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The last 2 decades have witnessed an unprecedented period of new antiepileptic drug (AED) development. Newer-generation AEDs have been developed with the intention of improving the ease of use, decreasing drug interactions, decreasing adverse side effects, and identifying drugs with unique mechanisms of action, some of which may bear relevance to potential neuroprotective activity. Drug trials have also been refined in some cases to evaluate AED efficacy in children and against distinct epilepsy syndromes. This progress provides many new treatment options for the child neurologist facing children with epilepsy but also introduces the burden of determining appropriate AED choices. Here we highlight 6 new antiepileptic medications recently approved or pending approval for use in the United States: lacosamide, rufinamide, vigabatrin, retigabine, brivaracetam, and clobazam. For each of these medications, we present information regarding the history of drug development, proposed mechanism(s) of action, pharmacokinetics and recommended dosing, evidence for clinical efficacy, tolerability, and when, available, any unique features that are relevant for the pediatric population.

Citing Articles

Brivaracetam add-on therapy for drug-resistant epilepsy.

Bresnahan R, Panebianco M, Marson A Cochrane Database Syst Rev. 2022; 3:CD011501.

PMID: 35285519 PMC: 8919456. DOI: 10.1002/14651858.CD011501.pub3.


Efficacy and Side Effect Profile of Clobazam in Children with Different Etiologies of Epilepsy from a Single Center.

Uzunhan T, Gor Z Sisli Etfal Hastan Tıp Bul. 2020; 54(2):236-244.

PMID: 32617066 PMC: 7326669. DOI: 10.14744/SEMB.2020.60252.


Brivaracetam add-on therapy for drug-resistant epilepsy.

Bresnahan R, Panebianco M, Marson A Cochrane Database Syst Rev. 2019; 3:CD011501.

PMID: 30920649 PMC: 6437881. DOI: 10.1002/14651858.CD011501.pub2.


Interactions Between Antiepileptic and Antibiotic Drugs: A Systematic Review and Meta-Analysis with Dosing Implications.

Carnovale C, Pozzi M, Mazhar F, Mosini G, Gentili M, Peeters G Clin Pharmacokinet. 2018; 58(7):875-886.

PMID: 30406474 DOI: 10.1007/s40262-018-0720-z.


CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy.

Djordjevic N, Dragas Milovanovic D, Radovanovic M, Radosavljevic I, Obradovic S, Jakovljevic M Eur J Clin Pharmacol. 2016; 72(4):439-45.

PMID: 26762380 DOI: 10.1007/s00228-015-2006-9.